Chapter 62 : Serologic and Molecular Tools for Diagnosing Infection

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Serologic and Molecular Tools for Diagnosing Infection, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815905/9781555813642_Chap62-1.gif /docserver/preview/fulltext/10.1128/9781555815905/9781555813642_Chap62-2.gif


In the last decade, there has been a dramatic resurgence of pertussis, particularly in adolescents and adults, likely as the result of a waning of vaccine induced immunity. Detection of the etiologic agent is the optimal method of making a laboratory diagnosis; however, with infections, the nature of the infection and the natural history of the infection make this difficult. Because of the difficulties with the test, DFA staining should only be used in conjunction with culture; some national surveillance systems do not accept DFA results as laboratory confirmation of pertussis infection. PCR is also less affected by antimicrobial effects than is cell culture, permitting laboratory diagnosis even after effective antibiotics have been initiated. The measurement of pertussis agglutinins is one of the oldest assays used for determining antibody titers against . Widely used in the early and mid-20th century, particularly in the Medical Research Council clinical trials that demonstrated the efficacy of whole-cell pertussis vaccines, pertussis agglutinins correlated well with population immunity to pertussis but did not predict individual protection. Pertussis toxin (PT) is the most important pertussis antigen and is responsible for many of the biological activities of . Proponents of the Chinese hamster ovary (CHO) cell neutralizing assay argue that the assay measures biologically active antibodies and thus might correlate better with protective antibodies. Improvements in serological diagnosis have the greatest potential for improving the laboratory diagnosis of pertussis, particularly as the epidemiology shifts from young infants and children to adolescents and adults.

Citation: Halperin S. 2006. Serologic and Molecular Tools for Diagnosing Infection, p 540-546. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch62
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of FIGURE 1

Algorithm for the laboratory diagnosis of pertussis.

Citation: Halperin S. 2006. Serologic and Molecular Tools for Diagnosing Infection, p 540-546. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch62
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Douglas, E.,, J. G. Coote,, R. Parton, and , W. McPheat. 1993. Identification of Bordetella pertussis in nasopharyngeal swabs by PCR amplification of a region of the adenylate cyclase gene. J. Med. Microbiol. 38: 140144.
2. Edelman, K.,, S. Nikkari,, O. Ruuskanen,, Q. He,, M. Viljanen, and , J. Mertsola. 1996. Detection of Bordetella pertussis by polymerase chain reaction and culture in the nasopharynx of erythromycin-treated infants with pertussis. Pediatr. Infect. Dis. J. 15: 5457.
3. Glare, E. M.,, J. C. Paton,, R. R. Premier,, A. J. Lawrence, and , I. T. Nisbet. 1990. Analysis of a repetitive DNA sequence from Bordetella pertussis and its application to the diagnosis of pertussis using the polymerase chain reaction. J. Clin. Microbiol. 28: 19821987.
4. Hallander, H. O. 1999. Microbiological and serological diagnosis of pertussis. Clin. Infect. Dis. 28(Suppl. 2): S99S106.
5. Hallander, H. O.,, E. Reizenstein,, B. Renemar,, G. Rasmusson,, L. Mardin, and , P. Olin. 1993. Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis. J. Clin. Microbiol. 31: 5052.
6. Halperin, S. A.,, R. Bortolussi, and , A. J. Wort. 1989. Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis. J. Clin. Microbiol. 27: 752757.
7. Halperin, S. A.,, E. L. Wang,, B. Law,, E. Mills,, R. Morris,, P. Déry,, M. Lebel,, N. MacDonald,, T. Jadavji,, W. Vaudry,, D. Scheifele,, G. Delage, and , P. Duclos. 1999. Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program—Active (IMPACT). Clin. Infect. Dis. 28: 12381243.
8. Houard, S.,, C. Hackel,, A. Herzog, and , A. Bollen. 1989. Specific identification of Bordetella pertussis by the polymerase chain reaction. Res. Microbiol. 140: 477487.
9. Kosters, K.,, M. Riffelmann, and , C. H. Wirsing von König. 2001. Evaluation of a real-time PCR assay for detection of Bordetella pertussis and B. parapertussis in clinical samples. J. Med. Microbiol. 50: 436440.
10. Li, Z.,, D. L. Jansen,, T. M. Finn,, S. A. Halperin,, A. Kasina,, S. P. O’Connor,, T. Aoyama,, C. R. Manclark, and , M. J. Brennan. 1994. Identification of Bordetella pertussis infection by shared-primer PCR. J. Clin. Microbiol. 32: 783789.
11. Loeffelholz, M. J. 2003. Bordetella, p. 780788. In P. R. Murray (ed.), Manual of Clinical Microbiology, 8th ed. ASM Press, Washington, D.C.
12. Lynn, F.,, G. F. Reed, and , B. Meade. 1996. Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens. Clin. Diagn. Lab. Immunol. 2: 689700.
13. Manclark, C. R.,, B. D. Meade, and , D. G. Burstyn. 1986. Serological response to Bordetella pertussis, p. 388394. In N. R. Rose,, H. Friedman, and , J. L. Fahey (ed.), Manual of Clinical Microbiology, 3rd ed. American Society for Microbiology, Washington, D.C.
14. McNicol, P.,, S. M. Giercke,, M. Gray,, D. Martin,, B. Brodeur,, M. S. Peppler,, T. Williams, and , G. Hammond. 1995. Evaluation and validation of a monoclonal immuno-fluorescent reagent for direct detection of Bordetella pertussis. J. Clin. Microbiol. 33: 28682871.
15. Meade, B. D.,, F. Lynn,, G. F. Reed,, C. M. Mink,, A. Romani,, A. Deforest, and , M. A. Deloria. 1994. Relationship between functional assays and enzyme immunoassays as measurements of responses to acellular and whole-cell pertussis vaccines. Pediatrics 96: 595600.
16. Medical Research Council. 1956. Vaccination against whooping cough: relation between protection in children and results of laboratory tests. Br. Med. J. 2: 454462.
17. Mink, C. M.,, C. H. O’Brien,, S. R. M. Wassilak,, A. Deforest, and , B. D. Meade. 1994. Isotype and antigen specificity of pertussis agglutinins following whole-cell pertussis vaccination and infection with Bordetella pertussis. Infect. Immun. 62: 11181120.
18. Mtiller, E. M. C.,, J. F. Hoppe, and , C. H. W. von König. 1997. Laboratory diagnosis of pertussis: state of the art in 1997. J. Clin. Microbiol. 35: 24352443.
19. National Advisory Committee on Immunization. 2003. Prevention of pertussis in adolescents and adults. Can. Commun. Dis. Rep. 29: 110.
20. Reizenstein, E.,, H. O. Hallander,, W. C. Blackwelder,, I. Kuhn,, M. Ljungman, and , R. Möllby. 1995. Comparison of five calculation methods for antibody ELISA procedures using pertussis serology as a model. J. Immunol. Methods 183: 279290.
21. Reizenstein, E.,, L. Lindberg,, R. Möllby, and , H. Hallander. 1996. Validation of nested PCR in pertussis vaccine trial. J. Clin. Microbiol. 34: 810815.
22. Senzilet, L. D.,, S. A. Halperin,, J. S. Spika,, M. Alagaratnam,, A. Morris,, B. Smith, and the Sentinel Health Unit Surveillance System Pertussis Working Group. 2001. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin. Infect. Dis. 32: 16911697.
23. Skowronski, D. M.,, G. De Serres,, D. MacDonald,, W. Wu,, C. Shaw,, J. Macnabb,, S. Champagne,, D. M. Patrick, and , S. A. Halperin. 2002. The changing age and seasonal profile of pertussis in Canada. J. Infect. Dis. 185: 14481453.
24. Taranger, J.,, B. Trollfors,, L. Lind,, G. Zackrisson, and , K. Beling-Holmquist. 1994. Environmental contamination leading to false-positive polymerase chain reaction for pertussis. Pediatr. Infect. Dis. J. 13: 936937.
25. Tomoda, T.,, H. Ogura, and , T. Kurashige. 1994. The longevity of the immune response to filamentous hemag-glutinin and pertussis toxin in patients with pertussis in a semiclosed community. J. Infect. Dis. 166: 908910.
26. Wadowsky, R. M.,, S. Laus,, T. Libert,, S. J. States, and , G. D. Ehrlich. 1994. Inhibition of PCR-based assay for Bordetella pertsussis by using calcium alginate fiber and aluminum shaft components of a nasopharyngeal swab. J. Clin. Microbiol. 32: 10541057.
27. Wortis, N.,, P. M. Strebel,, M. Wharton,, B. Bardenheier, and , I. R. Hardy. 1996. Pertussis deaths: report of 23 cases in the United States, 1992 and 1993. Pediatrics 97: 607612.
28. Yih, W. K.,, S. M. Lett,, F. N. des Vignes,, K. M. Carrison,, P. L. Sipe, and , C. D. Marchant. 2000. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J. Infect. Dis. 182: 14091416.


Generic image for table

Characteristics of diagnostic tests for detection of

Citation: Halperin S. 2006. Serologic and Molecular Tools for Diagnosing Infection, p 540-546. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch62

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error